{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:21:45Z","timestamp":1790500905999,"version":"4.1.0"},"reference-count":80,"publisher":"Bentham Science Publishers Ltd.","issue":"14","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDT"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Elabela, a bioactive micropeptide, is recognized as the second endogenous ligand for Apelin receptor and is widely distributed in different tissues and organs. Elabela plays important role in various physiological processes such blood pressure control, heart morphogenesis, apoptosis, angiogenesis, cell proliferation, migration, etc. Elabela is also implicated in pathological conditions like cardiac dysfunctions, heart failure, hypertension, kidney diseases, cancer and CNS disorders. The association of Elabela with these disease conditions makes it a potential target for their therapy. This review summarizes physiological role of Elabela peptide as well as its implication in various disease conditions.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389450123666220826160123","type":"journal-article","created":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T09:37:58Z","timestamp":1661593078000},"page":"1304-1318","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Elabela Peptide: An Emerging Target in Therapeutics"],"prefix":"10.2174","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4302-9300","authenticated-orcid":true,"given":"Lokesh Kumar","family":"Bhatt","sequence":"first","affiliation":[{"name":"Department of Pharmacology, SVKM\u2019s Dr. Bhanuben Nanavati College of Pharmacy, Vile Parle (W), Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maneesha","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, SVKM\u2019s Dr. Bhanuben Nanavati College of Pharmacy, Vile Parle (W), Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kedar S.","family":"Prabhavalkar","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, SVKM\u2019s Dr. Bhanuben Nanavati College of Pharmacy, Vile Parle (W), Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1021\/acs.jmedchem.5b01549","volume":"59","author":"Murza A.","year":"2016","unstructured":"Murza A.; Sainsily X.; Coquerel D.; Discovery and structure-activity relationship of a bioactive fragment of ELABELA that modulates vascular and cardiac functions. J Med Chem 2016,59(7),2962-2972","journal-title":"J Med Chem"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1124\/pr.119.017533","volume":"71","author":"Read C.","year":"2019","unstructured":"Read C.; Nyimanu D.; Williams T.L.; International union of basic and clinical pharmacology. CVII. Structure and pharmacology of the apelin receptor with a recommendation that elabela\/toddler is a second endogenous peptide ligand. Pharmacol Rev 2019,71(4),467-502","journal-title":"Pharmacol Rev"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.gep.2010.02.001","volume":"10","author":"Hassan A.S.","year":"2010","unstructured":"Hassan A.S.; Hou J.; Wei W.; Hoodless P.A.; Expression of two novel transcripts in the mouse definitive endoderm. Gene Expr Patterns 2010,10(2-3),127-134","journal-title":"Gene Expr Patterns"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s00395-015-0521-6","volume":"111","author":"Perj\u00e9s \u00c1.","year":"2016","unstructured":"Perj\u00e9s \u00c1.; Kilpi\u00f6 T.; Ulvila J.; Characterization of apela, a novel endogenous ligand of apelin receptor, in the adult heart. Basic Res Cardiol 2016,111(1),2","journal-title":"Basic Res Cardiol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1016\/j.bmcl.2009.06.008","volume":"19","author":"Torino D.","year":"2009","unstructured":"Torino D.; Mollica A.; Pinnen F.; Synthesis and evaluation of new endomorphin analogues modified at the Pro(2) residue. Bioorg Med Chem Lett 2009,19(15),4115-4118","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"105219","DOI":"10.1016\/j.bioorg.2021.105219","volume":"115","author":"Della Valle A.","year":"2021","unstructured":"Della Valle A.; Stefanucci A.; Scioli G.; Selective MOR activity of DAPEA and Endomorphin-2 analogues containing a (R)-\u03b3-Freidinger lactam in position two. Bioorg Chem 2021,115,105219","journal-title":"Bioorg Chem"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1093\/abbs\/gmu032","volume":"46","author":"Xie F.","year":"2014","unstructured":"Xie F.; Lv D.; Chen L.; ELABELA: a novel hormone in cardiac development acting as a new endogenous ligand for the APJ receptor. Acta Biochim Biophys Sin 2014,46(7),620-622","journal-title":"Acta Biochim Biophys Sin"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.33140\/JGRM.04.03.04","volume":"4","author":"Yavuzkir S.","year":"2020","unstructured":"Yavuzkir S.; Ustebay S.; Ugur K.; Elabela, nitric oxide and apelin in women with polycystic ovary syndrome. J Gynecol Reprod Med 2020,4(3),3-8","journal-title":"J Gynecol Reprod Med"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.peptides.2019.04.005","volume":"114","author":"Zhang Y.","year":"2019","unstructured":"Zhang Y.; Wang Y.; Luo M.; Elabela protects against podocyte injury in mice with streptozocin-induced diabetes by associating with the PI3K\/Akt\/mTOR pathway. Peptides 2019,114,29-37","journal-title":"Peptides"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"658253","DOI":"10.3389\/fonc.2021.658253","volume":"11","author":"Liu L.","year":"2021","unstructured":"Liu L.; Yi X.; Lu C.; Study progression of Apelin\/APJ signaling and apela in different types of cancer. Front Oncol 2021,11,658253","journal-title":"Front Oncol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"11406","DOI":"10.1073\/pnas.1936664100","volume":"100","author":"Azzi M.","year":"2003","unstructured":"Azzi M.; Charest P.G.; Angers S.; Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors. Proc Natl Acad Sci USA 2003,100(20),11406-11411","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"243","DOI":"10.21037\/atm.2020.02.07","volume":"8","author":"Liu W.","year":"2020","unstructured":"Liu W.; Yan J.; Pan W.; Tang M.; Apelin\/Elabela-APJ: a novel therapeutic target in the cardiovascular system. Ann Transl Med 2020,8(5),243-3","journal-title":"Ann Transl Med"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.peptides.2018.04.011","volume":"111","author":"Kuba K.","year":"2019","unstructured":"Kuba K.; Sato T.; Imai Y.; Yamaguchi T.; Apelin and Elabela\/Toddler; double ligands for APJ\/Apelin receptor in heart development, physiology, and pathology. Peptides 2019,111,62-70","journal-title":"Peptides"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s12079-021-00640-4","volume":"16","author":"Dagamajalu S.","year":"2022","unstructured":"Dagamajalu S.; Rex D.A.B.; Suchitha G.P.; Rai A.B.; Rainey J.K.; Prasad T.S.K.; The network map of Elabela signaling pathway in physiological and pathological conditions. J Cell Commun Signal 2022,16(1),145-154","journal-title":"J Cell Commun Signal"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"E1218","DOI":"10.1152\/ajpendo.00257.2019","volume":"317","author":"Georgiadou D.","year":"2019","unstructured":"Georgiadou D.; Boussata S.; van Dijk M.; ELABELA measurements by commercial ELISA kits require sample extraction. Am J Physiol Endocrinol Metab 2019,317(6),E1218-E1219","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.devcel.2013.11.002","volume":"27","author":"Chng S.C.","year":"2013","unstructured":"Chng S.C.; Ho L.; Tian J.; Reversade B.; ELABELA: a hormone essential for heart development signals via the apelin receptor. Dev Cell 2013,27(6),672-680","journal-title":"Dev Cell"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/s41581-021-00461-z","volume":"17","author":"Chapman F.A.","year":"2021","unstructured":"Chapman F.A.; Nyimanu D.; Maguire J.J.; Davenport A.P.; Newby D.E.; Dhaun N.; The therapeutic potential of apelin in kidney disease. Nat Rev Nephrol 2021,17(12),840-853","journal-title":"Nat Rev Nephrol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s10741-020-09957-5","volume":"26","author":"Ma Z.","year":"2021","unstructured":"Ma Z.; Song J-J.; Martin S.; Yang X-C.; Zhong J-C.; The Elabela-APJ axis: a promising therapeutic target for heart failure. Heart Fail Rev 2021,26(5),1249-1258","journal-title":"Heart Fail Rev"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"787","DOI":"10.3892\/ijmm.16.5.787","volume":"16","author":"Hashimoto Y.","year":"2005","unstructured":"Hashimoto Y.; Ishida J.; Yamamoto R.; G protein-coupled APJ receptor signaling induces focal adhesion formation and cell motility. Int J Mol Med 2005,16(5),787-792","journal-title":"Int J Mol Med"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1161\/01.RES.0000033522.37861.69","volume":"91","author":"Szokodi I.","year":"2002","unstructured":"Szokodi I.; Tavi P.; F\u00f6ldes G.; Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circ Res 2002,91(5),434-440","journal-title":"Circ Res"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.cmet.2008.10.003","volume":"8","author":"Dray C.","year":"2008","unstructured":"Dray C.; Knauf C.; Daviaud D.; Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metab 2008,8(5),437-445","journal-title":"Cell Metab"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s41580-018-0049-3","volume":"19","author":"Wootten D.","year":"2018","unstructured":"Wootten D.; Christopoulos A.; Marti-Solano M.; Babu M.M.; Sexton P.M.; Mechanisms of signalling and biased agonism in G protein-coupled receptors. Nat Rev Mol Cell Biol 2018,19(10),638-653","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"10464","DOI":"10.1073\/pnas.0403518101","volume":"101","author":"De Mota N.","year":"2004","unstructured":"De Mota N.; Reaux-Le Goazigo A.; El Messari S.; Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release. Proc Natl Acad Sci USA 2004,101(28),10464-10469","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1161\/CIRCULATIONAHA.116.023218","volume":"135","author":"Yang P.","year":"2017","unstructured":"Yang P.; Read C.; Kuc R.E.; Elabela\/toddler is an endogenous agonist of the apelin apj receptor in the adult cardiovascular system, and exogenous administration of the peptide compensates for the downregulation of its expression in pulmonary arterial hypertension. Circulation 2017,135(12),1160-1173","journal-title":"Circulation"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"632886","DOI":"10.3389\/fphys.2021.632886","volume":"12","author":"Hu G.","year":"2021","unstructured":"Hu G.; Wang Z.; Zhang R.; Sun W.; Chen X.; The role of apelin\/apelin receptor in energy metabolism and water homeostasis: a comprehensive narrative review. Front Physiol 2021,12,632886","journal-title":"Front Physiol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"6472","DOI":"10.1002\/jcp.26492","volume":"233","author":"Xu J.","year":"2018","unstructured":"Xu J.; Chen L.; Jiang Z.; Li L.; Biological functions of Elabela, a novel endogenous ligand of APJ receptor. J Cell Physiol 2018,233(9),6472-6482","journal-title":"J Cell Physiol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.peptides.2012.07.012","volume":"37","author":"Cheng B.","year":"2012","unstructured":"Cheng B.; Chen J.; Bai B.; Xin Q.; Neuroprotection of apelin and its signaling pathway. Peptides 2012,37(1),171-173","journal-title":"Peptides"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/s41419-020-02912-0","volume":"11","author":"Chen Z.","year":"2020","unstructured":"Chen Z.; Wu C.; Liu Y.; ELABELA attenuates deoxycorticosterone acetate\/salt-induced hypertension and renal injury by inhibition of NADPH oxidase\/ROS\/NLRP3 inflammasome pathway. Cell Death Dis 2020,11(8),698","journal-title":"Cell Death Dis"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"F1122","DOI":"10.1152\/ajprenal.00606.2019","volume":"318","author":"Xu C.","year":"2020","unstructured":"Xu C.; Wang F.; Chen Y.; ELABELA antagonizes intrarenal renin-angiotensin system to lower blood pressure and protects against renal injury. Am J Physiol Renal Physiol 2020,318(5),F1122-F1135","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BSR20192397","volume":"40","author":"Xu F.","year":"2020","unstructured":"Xu F.; Zhou H.; Wu M.; Fc-Elabela fusion protein attenuates lipopolysaccharide-induced kidney injury in mice. Biosci Rep 2020,40(9),1-11","journal-title":"Biosci Rep"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/jcmm.16052","volume":"25","author":"Li C.","year":"2021","unstructured":"Li C.; Miao X.; Wang S.; Elabela may regulate SIRT3-mediated inhibition of oxidative stress through Foxo3a deacetylation preventing diabetic-induced myocardial injury. J Cell Mol Med 2021,25(1),323-332","journal-title":"J Cell Mol Med"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/jci.insight.129070","volume":"5","author":"Soulet F.","year":"2020","unstructured":"Soulet F.; Bodineau C.; Hooks K.B.; ELA\/APELA precursor cleaved by furin displays tumor suppressor function in renal cell carcinoma through mTORC1 activation. JCI Insight 2020,5(14),1-21","journal-title":"JCI Insight"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1536\/ihj.20-817","volume":"62","author":"Tian Q-P","year":"2021","unstructured":"Tian Q-P; Liu M-L; Zhang Y-R; Plasma level of elabela in patients with coronary heart disease and its correlation with the disease classification. Int Heart J 2021,62(4),752-755","journal-title":"Int Heart J"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"e008900","DOI":"10.1161\/CIRCINTERVENTIONS.119.008900","volume":"13","author":"Megaly M","year":"2020","unstructured":"Megaly M; Xenogiannis I; Abi Rafeh N; Retrograde approach to chronic total occlusion percutaneous coronary intervention. Circ Cardiovasc Interv 2020,13(5),e008900","journal-title":"Circ Cardiovasc Interv"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"84","DOI":"10.4244\/EIJV4I1A15","volume":"4","author":"Sianos G.","year":"2008","unstructured":"Sianos G.; Barlis P.; Di Mario C.; European experience with the retrograde approach for the recanalisation of coronary artery chronic total occlusions. A report on behalf of the euroCTO club. EuroIntervention 2008,4(1),84-92","journal-title":"EuroIntervention"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.3389\/fphys.2019.01618","volume":"10","author":"Negri S.","year":"2020","unstructured":"Negri S.; Faris P.; Berra-Romani R.; Guerra G.; Moccia F.; Endothelial transient receptor potential channels and vascular remodeling: extracellular Ca entry for angiogenesis, arteriogenesis and vasculogenesis. Front Physiol 2020,10,1618","journal-title":"Front Physiol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"503","DOI":"10.36660\/abc.20200492","volume":"117","author":"Yavuz F.","year":"2021","unstructured":"Yavuz F.; Kaplan M.; Associa\u00e7\u00e3o entre os n\u00edveis s\u00e9ricos de elabela e oclus\u00e3o total cr\u00f4nica em pacientes com angina pectoris est\u00e1vel. Arq Bras Cardiol 2021,117(3),503-510","journal-title":"Arq Bras Cardiol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1111\/febs.14055","volume":"284","author":"He J.","year":"2017","unstructured":"He J.; Zhang G.; Pang Q.; SIRT6 reduces macrophage foam cell formation by inducing autophagy and cholesterol efflux under ox-LDL condition. FEBS J 2017,284(9),1324-1337","journal-title":"FEBS J"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"138","DOI":"10.7150\/ijbs.28873","volume":"15","author":"Shi Y.","year":"2019","unstructured":"Shi Y.; Wang S.; Peng H.; Fibroblast growth factor 21 attenuates vascular calcification by alleviating endoplasmic reticulum stress mediated apoptosis in rats. Int J Biol Sci 2019,15(1),138-147","journal-title":"Int J Biol Sci"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1161\/CIRCRESAHA.110.219279","volume":"107","author":"Thomas M.C.","year":"2010","unstructured":"Thomas M.C.; Pickering R.J.; Tsorotes D.; Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse. Circ Res 2010,107(7),888-897","journal-title":"Circ Res"},{"key":"ref=41","first-page":"4467","volume":"12","author":"Yu P.","year":"2020","unstructured":"Yu P.; Ma S.; Dai X.; Cao F.; Elabela alleviates myocardial ischemia reperfusion-induced apoptosis, fibrosis and mitochondrial dysfunction through PI3K\/AKT signaling. Am J Transl Res 2020,12(8),4467-4477","journal-title":"Am J Transl Res"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1146\/annurev-genet-102108-134850","volume":"43","author":"Wang C.","year":"2009","unstructured":"Wang C.; Youle R.J.; The role of mitochondria in apoptosis. Annu Rev Genet 2009,43(1),95-118","journal-title":"Annu Rev Genet"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/10520295.2019.1653497","volume":"95","author":"Aydin S.","year":"2020","unstructured":"Aydin S.; Kuloglu T.; Aydin Y.; Effects of iloprost and sildenafil treatment on elabela, apelin-13, nitric oxide, and total antioxidant and total oxidant status in experimental enzyme-positive acute coronary syndrome in rats. Biotech Histochem 2020,95(2),145-151","journal-title":"Biotech Histochem"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"674","DOI":"10.11909\/j.issn.1671-5411.2020.11.004","volume":"17","author":"Du S.L.","year":"2020","unstructured":"Du S.L.; Yang X.C.; Zhong J.C.; Wang L.F.; Fan Y.F.; Plasma levels of Elabela are associated with coronary angiographic severity in patients with acute coronary syndrome. J Geriatr Cardiol 2020,17(11),674-679","journal-title":"J Geriatr Cardiol"},{"key":"ref=45","first-page":"503","volume":"117","author":"Yavuz F.","year":"2021","unstructured":"Yavuz F.; Association between serum elabela levels and chronic totally occlusion in patients with stable angina pectoris. Arq Bras Cardiol 2021,117,503-510","journal-title":"Arq Bras Cardiol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"683","DOI":"10.21470\/1678-9741-2019-0461","volume":"35","author":"Acele A.","year":"2020","unstructured":"Acele A.; Bulut A.; Donmez Y.; Koc M.; Serum elabela level significantly increased in patients with complete heart block. Rev Bras Cir Cardiovasc 2020,35(5),683-688","journal-title":"Rev Bras Cir Cardiovasc"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.tips.2015.06.002","volume":"36","author":"Yang P.","year":"2015","unstructured":"Yang P.; Maguire J.J.; Davenport A.P.; Apelin, Elabela\/Toddler, and biased agonists as novel therapeutic agents in the cardiovascular system. Trends Pharmacol Sci 2015,36(9),560-567","journal-title":"Trends Pharmacol Sci"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"638468","DOI":"10.3389\/fcvm.2021.638468","volume":"8","author":"Ma Z.","year":"2021","unstructured":"Ma Z.; Zhao L.; Martin S.; Lower plasma elabela levels in hypertensive patients with heart failure predict the occurrence of major adverse cardiac events: a preliminary study. Front Cardiovasc Med 2021,8,638468","journal-title":"Front Cardiovasc Med"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.32596\/ejcm.galenos.2020.11.059","volume":"8","author":"Bulut A.","year":"2020","unstructured":"Bulut A.; Acele A.; D\u00f6nmez Y.; S\u00fcmb\u00fcl H.E.; Ko\u00e7 M.; Increased serum elabela level related to NT-proBNP in patients with heart failure. Eur J Cardiovasc Med 2020,8(1),1-9","journal-title":"Eur J Cardiovasc Med"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ijcard.2019.04.089","volume":"292","author":"Xi Y.","year":"2019","unstructured":"Xi Y.; Yu D.; Yang R.; Recombinant Fc-Elabela fusion protein has extended plasma half-life andmitigates post-infarct heart dysfunction in rats. Int J Cardiol 2019,292,180-187","journal-title":"Int J Cardiol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"e17645","DOI":"10.1097\/MD.0000000000017645","volume":"98","author":"D\u00f6nmez Y.","year":"2019","unstructured":"D\u00f6nmez Y.; Acele A.; Increased Elabela levels in the acute ST segment elevation myocardial infarction patients. Medicine 2019,98(43),e17645","journal-title":"Medicine"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s10989-018-9707-8","volume":"25","author":"Rakhshan K.","year":"2019","unstructured":"Rakhshan K.; Azizi Y.; Naderi N.; Ghardashi Afousi A.; Aboutaleb N.; ELABELA (ELA) peptide exerts cardioprotection against myocardial infarction by targeting oxidative stress and the improvement of heart function. Int J Pept Res Ther 2019,25(2),613-621","journal-title":"Int J Pept Res Ther"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"8537","DOI":"10.1111\/jcmm.16814","volume":"25","author":"Jin L.","year":"2021","unstructured":"Jin L.; Pan Y.; Li Q.; Li J.; Wang Z.; Elabela gene therapy promotes angiogenesis after myocardial infarction. J Cell Mol Med 2021,25(17),8537-8545","journal-title":"J Cell Mol Med"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"119065","DOI":"10.1016\/j.bbamcr.2021.119065","volume":"1868","author":"Liet B.","year":"2021","unstructured":"Liet B.; Nys N.; Siegfried G.; Elabela\/toddler: New peptide with a promising future in cancer diagnostic and therapy. Biochim Biophys Acta Mol Cell Res 2021,1868(9),119065","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"772","DOI":"10.20945\/2359-3997000000293","volume":"64","author":"Bankir M.","year":"2021","unstructured":"Bankir M.; Abayli C.; Acibucu F.; Importance of ELABELA in the differential diagnosis of benign and malignant lesions of the thyroid gland. Arch Endocrinol Metab 2021,64(6),772-778","journal-title":"Arch Endocrinol Metab"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"989","DOI":"10.5137\/1019-5149.JTN.22022-17.2","volume":"28","author":"Artas G.","year":"2018","unstructured":"Artas G.; Ozturk S.; Kuloglu T.; A novel candidate molecule in pathological grading of gliomas: elabela. Turk Neurosurg 2018,28(6),989-994","journal-title":"Turk Neurosurg"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3390\/ph12010045","volume":"12","author":"Ganguly D.","year":"2019","unstructured":"Ganguly D.; Cai C.; Sims M.M.; APELA expression in glioma, and its association with patient survival and tumor grade. Pharmaceuticals 2019,12(1),45","journal-title":"Pharmaceuticals"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1186\/s12885-019-6325-6","volume":"19","author":"Acik D.Y.","year":"2019","unstructured":"Acik D.Y.; Bankir M.; Baylan F.A.; Aygun B.; Can ELABELA be a novel target in the treatment of chronic lymphocytic leukaemia? BMC Cancer 2019,19(1),1086","journal-title":"BMC Cancer"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.stem.2015.08.010","volume":"17","author":"Ho L.","year":"2015","unstructured":"Ho L.; Tan S.Y.X.; Wee S.; ELABELA is an endogenous growth factor that sustains hesc self-renewal via the PI3K\/AKT pathway. Cell Stem Cell 2015,17(4),435-447","journal-title":"Cell Stem Cell"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3389\/fonc.2019.00192","volume":"9","author":"McBride A.","year":"2019","unstructured":"McBride A.; Houtmann S.; Wilde L.; The role of inhibition of apoptosis in acute leukemias and myelodysplastic syndrome. Front Oncol 2019,9,192","journal-title":"Front Oncol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.ygyno.2017.10.016","volume":"147","author":"Yi Y.","year":"2017","unstructured":"Yi Y.; Tsai S-H.; Cheng J-C.; APELA promotes tumour growth and cell migration in ovarian cancer in a p53-dependent manner. Gynecol Oncol 2017,147(3),663-671","journal-title":"Gynecol Oncol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.stem.2015.04.002","volume":"16","author":"Li M.","year":"2015","unstructured":"Li M.; Gou H.; Tripathi B.K.; An apela RNA-containing negative feedback loop regulates p53-mediated apoptosis in embryonic stem cells. Cell Stem Cell 2015,16(6),669-683","journal-title":"Cell Stem Cell"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"386","DOI":"10.4103\/NJCP.NJCP_105_18","volume":"22","author":"Artas G.","year":"2019","unstructured":"Artas G.; Kuloglu T.; Dagli A.F.; A promising biomarker to distinguish benign and malignant renal tumors: ELABELA. Niger J Clin Pract 2019,22(3),386-392","journal-title":"Niger J Clin Pract"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1681\/ASN.2016111210","volume":"28","author":"Chen H.","year":"2017","unstructured":"Chen H.; Wang L.; Wang W.; ELABELA and an ELABELA fragment protect against AKI. J Am Soc Nephrol 2017,28(9),2694-2707","journal-title":"J Am Soc Nephrol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.7150\/ijbs.7.1056","volume":"7","author":"Lan H.Y.","year":"2011","unstructured":"Lan H.Y.; Diverse roles of TGF-\u03b2\/Smads in renal fibrosis and inflammation. Int J Biol Sci 2011,7(7),1056-1067","journal-title":"Int J Biol Sci"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1161\/01.HYP.27.5.1121","volume":"27","author":"Campbell W.G.","year":"1996","unstructured":"Campbell W.G.; Gahnem F.; Catanzaro D.F.; Plasma and renal prorenin\/renin, renin mRNA, and blood pressure in Dahl salt-sensitive and salt-resistant rats. Hypertension 1996,27(5),1121-1133","journal-title":"Hypertension"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"147032031665385","DOI":"10.1177\/1470320316653858","volume":"17","author":"Pavlov T.S.","year":"2016","unstructured":"Pavlov T.S.; Levchenko V.; Ilatovskaya D.V.; Moreno C.; Staruschenko A.; Renal sodium transport in renin-deficient Dahl salt-sensitive rats. J Renin Angiotensin Aldosterone Syst 2016,17(3),147032031665385","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1016\/j.febslet.2010.04.025","volume":"584","author":"Foussal C.","year":"2010","unstructured":"Foussal C.; Lairez O.; Calise D.; Activation of catalase by apelin prevents oxidative stress-linked cardiac hypertrophy. FEBS Lett 2010,584(11),2363-2370","journal-title":"FEBS Lett"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1080\/0886022X.2020.1792926","volume":"42","author":"Lu X.","year":"2020","unstructured":"Lu X.; Liu S.; Luan R.; Serum elabela and apelin levels during different stages of chronic kidney disease. Ren Fail 2020,42(1),667-672","journal-title":"Ren Fail"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1248636","DOI":"10.1126\/science.1248636","volume":"343","author":"Pauli A.","year":"2014","unstructured":"Pauli A.; Norris M.L.; Valen E.; Toddler: An embryonic signal that promotes cell movement via apelin receptors. Science 2014,343,1248636","journal-title":"Science"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"8170","DOI":"10.1038\/srep08170","volume":"5","author":"Wang Z.","year":"2015","unstructured":"Wang Z.; Yu D.; Wang M.; Elabela-apelin receptor signaling pathway is functional in mammalian systems. Sci Rep 2015,5(1),8170","journal-title":"Sci Rep"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"18261","DOI":"10.1074\/jbc.M115.648238","volume":"290","author":"Deng C","year":"2015","unstructured":"Deng C; Chen H; Yang N; Feng Y; Hsueh AJW; Apela regulates fluid homeostasis by binding to the APJ receptor to activate Gi signaling. J Biol Chem 2015,290(30),18261-18268","journal-title":"J Biol Chem"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"e1139","DOI":"10.1097\/CCM.0000000000002639","volume":"45","author":"Coquerel D","year":"2017","unstructured":"Coquerel D; Chagnon F; Sainsily X; ELABELA improves cardio-renal outcome in fatal experimental septic shock. Crit Care Med 2017,45(11),e1139-e1148","journal-title":"Crit Care Med"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2174\/1566523217666161121111906","volume":"16","author":"Schreiber C.A.","year":"2017","unstructured":"Schreiber C.A.; Holditch S.J.; Generous A.; Ikeda Y.; Sustained ELABELA gene therapy in high-salt diet-induced hypertensive rats. Curr Gene Ther 2017,16(5),349-360","journal-title":"Curr Gene Ther"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1097\/WNR.0000000000000431","volume":"26","author":"Santoso P.","year":"2015","unstructured":"Santoso P.; Maejima Y.; Kumamoto K.; Takenoshita S.; Shimomura K.; Central action of ELABELA reduces food intake and activates arginine vasopressin and corticotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus. Neuroreport 2015,26(14),820-826","journal-title":"Neuroreport"},{"key":"ref=76","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-76159\/v1","author":"Wang J.","year":"2020","unstructured":"Wang J.; Duan J.; Huang S.; Hu D.; Chen H.; Mu F.;  Elabela-APLNR inhibits cerebral ischemia\/reperfusion injury through AMPK\/SIRT3\/PGC-1\u03b1 and Akt\/Nrf2 pathways 2020","journal-title":"Elabela-APLNR inhibits cerebral ischemia\/reperfusion injury through AMPK\/SIRT3\/PGC-1\u03b1 and Akt\/Nrf2 pathways"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3389\/fphys.2015.00139","volume":"6","author":"Nasyrova R.F.","year":"2015","unstructured":"Nasyrova R.F.; Ivashchenko D.V.; Ivanov M.V.; Neznanov N.G.; Role of nitric oxide and related molecules in schizophrenia pathogenesis: biochemical, genetic and clinical aspects. Front Physiol 2015,6,139","journal-title":"Front Physiol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"184","DOI":"10.2478\/jomb-2019-0029","volume":"39","author":"Catak Z.","year":"2020","unstructured":"Catak Z.; Kaya H.; Kocdemir E.; Interaction of apelin, elabela and nitric oxide in schizophrenia patients. J Med Biochem 2020,39(2),184-190","journal-title":"J Med Biochem"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1080\/10520295.2020.1714732","volume":"95","author":"Eser Karlidag G.","year":"2020","unstructured":"Eser Karlidag G.; Arslan Solmaz O.; Are adropin, apelin, elabela, asprosin and betatrophin biomarkers for chronic hepatitis and staging of fibrosis? Biotech Histochem 2020,95(2),152-159","journal-title":"Biotech Histochem"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"330","DOI":"10.14744\/AnatolJCardiol.2020.17329","volume":"25","author":"Kaplan M.","year":"2020","unstructured":"Kaplan M.; Elabela as a novel marker; well-correlated with wifi amputation risk score in patients with lower extremity arterial disease. Anatol J Cardiol 2020,25,330-337","journal-title":"Anatol J Cardiol"}],"container-title":["Current Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389450123666220826160123","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/208053\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389450123666220826160123","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,11]],"date-time":"2022-12-11T07:44:38Z","timestamp":1670744678000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/208053\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":80,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389450123666220826160123","relation":{},"ISSN":["1389-4501"],"issn-type":[{"value":"1389-4501","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-02-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-23","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}